The FDA granted orphan drug designation and fast track designation to Lacripep, according to a press release from TearSolutions. If approved, Lacripep would be the second treatment indicated for ...
Ty Pendlebury is CNET's senior editor for TV and home audio, and author of the daily Insider newsletter. He has rigorously tested, reviewed and written about AV equipment for the company since 2006.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results